✦ LIBER ✦

373 RANDOMIZED OPEN LABEL COMPARATIVE STUDY OF EFFICACY AND SAFETY OF COMBINATION (CIPROFLOXACIN+DOXAZOSIN) VS. MONOTHERAPY (CIPROFLOXACIN) IN PATIENTS WITH CATEGORY II OR CATEGORY IMA PROSTATITIS

✍ Scribed by K.L. Lokshin; Y.G. Alyaev; A.Z. Vinarov; L.G. Spivak

Book ID: 119621108
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 78 KB
Volume: 9
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(10)60371-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

I-COMBINE Study: Assessment of Efficacy

I-COMBINE Study: Assessment of Efficacy and Safety Profile of Irbesartan/Amlodipine Fixed-Dose Combination Therapy Compared With Amlodipine Monotherapy in Hypertensive Patients Uncontrolled With Amlodipine 5 mg Monotherapy: A Multicenter, Phase III, Prospective, Randomized, Open-Label With Blinded–End Point Evaluation Study

✍ Bobrie, Guillaume 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 666 KB

I-ADD Study: Assessment of Efficacy and

I-ADD Study: Assessment of Efficacy and Safety Profile of Irbesartan/Amlodipine Fixed-Dose Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled With Irbesartan 150 mg Monotherapy: A Multicenter, Phase III, Prospective, Randomized, Open-Label With Blinded–End Point Evaluation Study

✍ Bobrie, Guillaume 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 592 KB

Phase II, Open-Label, Randomized, Multic

Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer

✍ Kaye, S. B.; Lubinski, J.; Matulonis, U.; Ang, J. E.; Gourley, C.; Karlan, B. Y. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 165 KB